1011 related articles for article (PubMed ID: 33726806)
1. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey.
Cattalini M; Della Paolera S; Zunica F; Bracaglia C; Giangreco M; Verdoni L; Meini A; Sottile R; Caorsi R; Zuccotti G; Fabi M; Montin D; Meneghel A; Consolaro A; Dellepiane RM; Maggio MC; La Torre F; Marchesi A; Simonini G; Villani A; Cimaz R; Ravelli A; Taddio A;
Pediatr Rheumatol Online J; 2021 Mar; 19(1):29. PubMed ID: 33726806
[TBL] [Abstract][Full Text] [Related]
2. Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review.
Cherqaoui B; Koné-Paut I; Yager H; Bourgeois FL; Piram M
Rheumatology (Oxford); 2021 Oct; 60(10):4530-4537. PubMed ID: 33493353
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.
Whittaker E; Bamford A; Kenny J; Kaforou M; Jones CE; Shah P; Ramnarayan P; Fraisse A; Miller O; Davies P; Kucera F; Brierley J; McDougall M; Carter M; Tremoulet A; Shimizu C; Herberg J; Burns JC; Lyall H; Levin M;
JAMA; 2020 Jul; 324(3):259-269. PubMed ID: 32511692
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological and Clinical Profile of Pediatric Inflammatory Multisystem Syndrome - Temporally Associated with SARS-CoV-2 (PIMS-TS) in Indian Children.
Dhanalakshmi K; Venkataraman A; Balasubramanian S; Madhusudan M; Amperayani S; Putilibai S; Sadasivam K; Ramachandran B; Ramanan AV
Indian Pediatr; 2020 Nov; 57(11):1010-1014. PubMed ID: 32769230
[TBL] [Abstract][Full Text] [Related]
5. Management of severe hyperinflammation in the COVID-19 era: the role of the rheumatologist.
Papadopoulou C; Al Obaidi M; Moraitis E; Compeyrot-Lacassagne S; Eleftheriou D; Brogan P
Rheumatology (Oxford); 2021 Feb; 60(2):911-917. PubMed ID: 33197261
[TBL] [Abstract][Full Text] [Related]
6. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study.
Davies P; Evans C; Kanthimathinathan HK; Lillie J; Brierley J; Waters G; Johnson M; Griffiths B; du Pré P; Mohammad Z; Deep A; Playfor S; Singh D; Inwald D; Jardine M; Ross O; Shetty N; Worrall M; Sinha R; Koul A; Whittaker E; Vyas H; Scholefield BR; Ramnarayan P
Lancet Child Adolesc Health; 2020 Sep; 4(9):669-677. PubMed ID: 32653054
[TBL] [Abstract][Full Text] [Related]
7. Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital.
Ramcharan T; Nolan O; Lai CY; Prabhu N; Krishnamurthy R; Richter AG; Jyothish D; Kanthimathinathan HK; Welch SB; Hackett S; Al-Abadi E; Scholefield BR; Chikermane A
Pediatr Cardiol; 2020 Oct; 41(7):1391-1401. PubMed ID: 32529358
[TBL] [Abstract][Full Text] [Related]
8. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.
Zhang QY; Xu BW; Du JB
World J Pediatr; 2021 Aug; 17(4):335-340. PubMed ID: 34013488
[TBL] [Abstract][Full Text] [Related]
9. Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome.
Pereira MFB; Litvinov N; Farhat SCL; Eisencraft AP; Gibelli MABC; Carvalho WB; Fernandes VR; Fink TT; Framil JVS; Galleti KV; Fante AL; Fonseca MFM; Watanabe A; Paula CSY; Palandri GG; Leal GN; Diniz MFR; Pinho JRR; Silva CA; Marques HHS; ; Rossi Junior A; Delgado AF; Andrade APM; Schvartsman C; Sabino EC; Rocha MC; Kanunfre KA; Okay TS; Carneiro-Sampaio MMS; Jorge PPD
Clinics (Sao Paulo); 2020; 75():e2209. PubMed ID: 32844958
[TBL] [Abstract][Full Text] [Related]
10. Cardiac pathology and outcomes vary between Kawasaki disease and PIMS-TS.
Felsenstein S; Duong P; Lane S; Jones C; Pain CE; Hedrich CM
Clin Immunol; 2021 Aug; 229():108780. PubMed ID: 34118400
[TBL] [Abstract][Full Text] [Related]
11. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2.
Henderson LA; Canna SW; Friedman KG; Gorelik M; Lapidus SK; Bassiri H; Behrens EM; Ferris A; Kernan KF; Schulert GS; Seo P; Son MBF; Tremoulet AH; Yeung RSM; Mudano AS; Turner AS; Karp DR; Mehta JJ
Arthritis Rheumatol; 2021 Apr; 73(4):e13-e29. PubMed ID: 33277976
[TBL] [Abstract][Full Text] [Related]
12. Severe acute respiratory syndrome coronavirus 2-related multisystem inflammatory syndrome in children mimicking Kawasaki disease.
Mercier JC; Ouldali N; Melki I; Basmaci R; Levy M; Titomanlio L; Beyler C; Meinzer U
Arch Cardiovasc Dis; 2021 May; 114(5):426-433. PubMed ID: 34052147
[TBL] [Abstract][Full Text] [Related]
13. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.
Chen MR; Kuo HC; Lee YJ; Chi H; Li SC; Lee HC; Yang KD
Front Immunol; 2021; 12():632890. PubMed ID: 33732254
[TBL] [Abstract][Full Text] [Related]
14. Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): a Brazilian cohort.
Cavalcanti A; Islabão A; Magalhães C; Veloso S; Lopes M; do Prado R; Aquilante B; Terrazas AM; Rezende MF; Clemente G; Terreri MT
Adv Rheumatol; 2022 Feb; 62(1):6. PubMed ID: 35189972
[TBL] [Abstract][Full Text] [Related]
15. Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2: A Case Series Quantitative Systematic Review.
Bustos B R; Jaramillo-Bustamante JC; Vasquez-Hoyos P; Cruces P; Díaz F
Pediatr Emerg Care; 2021 Jan; 37(1):44-47. PubMed ID: 33181794
[TBL] [Abstract][Full Text] [Related]
16. Multicentre observational study on multisystem inflammatory syndrome related to COVID-19 in Argentina.
Vainstein E; Baleani S; Urrutia L; Affranchino N; Ackerman J; Cazalas M; Goldsman A; Sardella A; Tolin AL; Goldaracena P; Fabi M; Cosentino M; Magliola R; Roggiero G; Manso P; Triguy J; Ballester C; Cervetto V; Vaccarello M; De Carli DN; De Carli ME; Ciotti AL; Sicurello MI; Rios Leiva C; Villalba C; Hortas M; Peña S; González G; Zold CL; Murer MG;
Pediatr Int; 2023 Jan; 65(1):e15431. PubMed ID: 36464947
[TBL] [Abstract][Full Text] [Related]
17. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.
Kabeerdoss J; Pilania RK; Karkhele R; Kumar TS; Danda D; Singh S
Rheumatol Int; 2021 Jan; 41(1):19-32. PubMed ID: 33219837
[TBL] [Abstract][Full Text] [Related]
18. Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Children: One Year after the Onset of the Pandemic in a High-Incidence Area.
Fabi M; Filice E; Biagi C; Andreozzi L; Palleri D; Mattesini BE; Rizzello A; Gabrielli L; Ghizzi C; Di Luca D; Caramelli F; De Fanti A; Lanari M
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696451
[TBL] [Abstract][Full Text] [Related]
19. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children.
Lee PY; Day-Lewis M; Henderson LA; Friedman KG; Lo J; Roberts JE; Lo MS; Platt CD; Chou J; Hoyt KJ; Baker AL; Banzon TM; Chang MH; Cohen E; de Ferranti SD; Dionne A; Habiballah S; Halyabar O; Hausmann JS; Hazen MM; Janssen E; Meidan E; Nelson RW; Nguyen AA; Sundel RP; Dedeoglu F; Nigrovic PA; Newburger JW; Son MBF
J Clin Invest; 2020 Nov; 130(11):5942-5950. PubMed ID: 32701511
[TBL] [Abstract][Full Text] [Related]
20. Risk factors of a severe course of pediatric multi-system inflammatory syndrome temporally associated with COVID-19.
Stasiak A; Perdas E; Smolewska E
Eur J Pediatr; 2022 Oct; 181(10):3733-3738. PubMed ID: 35948653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
